Rankings
▼
Calendar
PBYI Q2 2023 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
$311M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$55M
-8.3% YoY
Gross Profit
$43M
78.3% margin
Operating Income
$5M
9.0% margin
Net Income
$2M
3.9% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
+3.4%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$200M
Total Liabilities
$170M
Stockholders' Equity
$30M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$55M
$60M
-8.3%
Gross Profit
$43M
$45M
-4.2%
Operating Income
$5M
$12M
-59.4%
Net Income
$2M
$9M
-77.3%
Revenue Segments
Product
$52M
94%
Royalty
$3M
6%
← FY 2023
All Quarters
Q3 2023 →